BTIG Reiterates Buy Rating on Progyny (PGNY)
Tweet Send to a Friend
BTIG analyst David Larsen reiterated a Buy rating and $30.00 price target on Progyny (NASDAQ: PGNY).The analyst comments "This morning ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


